Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-02-27

FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved Teva's supplemental application for EPITOL (carbamazepine). This approval pertains to a supplemental filing for the product submitted by Teva P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPITOL (carbamazepine)

Snippet

SUPPL AP for EPITOL (CARBAMAZEPINE)